These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31544232)

  • 1. The clinical conundrum of managing 5-fluorouracil-induced vasospasm in colorectal carcinoma.
    Nohria A
    Cancer; 2019 Dec; 125(24):4346-4349. PubMed ID: 31544232
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors in human colorectal cancer.
    Bianco AR; Carlomagno C; De Laurentiis M; De Placido S; Tortora G; Ciardiello F
    Tumori; 1997; 83(1 Suppl):S15-8. PubMed ID: 9154061
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive values of sex and tumour site for survival benefit from 5FU in colorectal cancer.
    Iacopetta B
    Br J Cancer; 2002 May; 86(9):1524-5; author reply 1525-6. PubMed ID: 11986790
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer.
    Daniele B; Secondulfo M; De Vivo R; Pignata S; De Magistris L; Delrio P; Palaia R; Barletta E; Tambaro R; Carratù R
    J Clin Gastroenterol; 2001 Mar; 32(3):228-30. PubMed ID: 11246350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymidylate synthase levels: prognostic, predictive, or both?
    Allegra C
    J Clin Oncol; 2002 Apr; 20(7):1711-3. PubMed ID: 11919223
    [No Abstract]   [Full Text] [Related]  

  • 7. X-ACT: an important step on an unfinished journey.
    Maughan T
    Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular biological analysis of 5-fluorouracil sensitivity in colorectal neoplasm].
    Kubota T; Yoshinare K; Kabeshima Y; Watanabe M; Kitajima M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():321-4. PubMed ID: 14574903
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer.
    Ji WB; Um JW; Ryu JS; Hong KD; Kim JS; Min BW; Joung SY; Lee JH; Kim YS
    Anticancer Res; 2017 May; 37(5):2679-2682. PubMed ID: 28476844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal carcinoma: therapeutic approach in patients already treated with metastasis resection].
    Bajetta E; Cappuzzo F
    Ann Ital Chir; 1996; 67(6):827-30. PubMed ID: 9214274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
    Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P;
    J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-therapeutic assessment of plasma dihydrouracil/uracil ratio for predicting the pharmacokinetic parameters of 5-fluorouracil and tumor growth in a rat model of colorectal cancer.
    Kobuchi S; Ito Y; Okada K; Imoto K; Kuwano S; Takada K
    Biol Pharm Bull; 2013; 36(6):907-16. PubMed ID: 23575271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy of colorectal cancer.
    Cunningham D; Starling N
    Lancet; 2007 Dec; 370(9604):1980-1. PubMed ID: 18083386
    [No Abstract]   [Full Text] [Related]  

  • 14. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
    Köhne CH; Wilke H; Schöffski P; Schmoll HJ
    J Infus Chemother; 1996; 6(4):206-10. PubMed ID: 9229317
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphisms in the thymidylate synthase gene predict response to 5-fluorouracil therapy in colorectal cancer.
    Gibson TB
    Clin Colorectal Cancer; 2006 Jan; 5(5):321-3. PubMed ID: 16512989
    [No Abstract]   [Full Text] [Related]  

  • 16. Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle.
    Tejpar S; Saridaki Z; Delorenzi M; Bosman F; Roth AD
    J Natl Cancer Inst; 2011 Jun; 103(11):841-4. PubMed ID: 21597023
    [No Abstract]   [Full Text] [Related]  

  • 17. [Colorectal carcinoma].
    Schulthess G; Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Nov; 94(44):1705-11; quiz 1712. PubMed ID: 16309014
    [No Abstract]   [Full Text] [Related]  

  • 18. Can the CIMP status be used to stratify the colorectal cancer patients who respond to adjuvant chemotherapy?
    Huh JW
    J Surg Oncol; 2011 Dec; 104(7):861-2. PubMed ID: 21695698
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of thymidylate synthase: biochemical pharmacology of drugs with activity in colorectal cancer.
    Jackman AL
    Tumori; 1997; 83(1 Suppl):S65-6. PubMed ID: 9154072
    [No Abstract]   [Full Text] [Related]  

  • 20. miR-200c as a Predictive Biomarker for 5-Fluorouracil Chemosensitivity in Colorectal Cancer.
    Karimi Dermani F; Najafi R
    J Gastrointest Cancer; 2018 Mar; 49(1):102-103. PubMed ID: 29218654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.